Literature DB >> 17988473

Assessing the performance, practices and roles of drug sellers/dispensers and mothers'/guardians' behaviour for common childhood conditions in Kibaha district, Tanzania.

S E D Nsimba1.   

Abstract

In most third world countries, self-medication is common and pharmacies, drug stores and drug shops are important providers of health advice and inexpensive medicines. We used exit interviews to assess drug sellers'/dispensers' roles and consumers' behaviour in Kibaha district, Coast region, Tanzania. Exit interviews with mothers/guardians reported the following childhood conditions treated with or without prescriptions at drug shops: respiratory infections (34%), fever (21%), a combination of diarrhoea, acute respiratory infection (ARI) and fever (14%), diarrhoea alone (13%) and other conditions (17%). The majority of drug sellers/dispensers prescribed or dispensed branded drugs (85%) for most mothers/guardians who visited these drug shops. In addition, antibiotics in total were prescribed for 31% of the mothers/guardians. Of the antibiotics dispensed, 38% were not prescribed by clinicians. In total, oral rehydration salts (ORSs) (3%), antimalarials (sulphadoxine/pyrimethamine) (24%) and antipyretics (11%), were prescribed in 20% but were bought by only 9%; multivitamins (6%), cough mixtures (4%) and other drugs (2%) (antihelminthics, benzylbenzoate emulsions, ear and eye drops) were also purchased from these facilities. Of the diarrhoea case histories presented by simulated clients at the drug shops, only 35% of the bloody diarrhoea scenarios were accurately diagnosed for getting antibiotics as compared with 44% for watery diarrhoea for which the use of antibiotics were wrongly advised (P<0.01). Furthermore, drug sellers/dispensers in these drug shops recommended use of ORS less frequently (3%) for a combination of diarrhoea, ARI and fever, and 2% for ARI alone than for watery (29%) and bloody diarrhoea (32%), respectively, for children under five years of age (P<0.001). Antimicrobial agents were advised for ARI (38%), watery diarrhoea (44%) and bloody diarrhoea (35%), respectively, with no significant difference among the three common childhood conditions. Antipyretics were advised in almost all childhood conditions but were least in watery (2%) and bloody diarrhoea (4%). This study demonstrates that antibiotics are overused in both the urban and rural settings of Kibaha district and that this is due to both clinicians'and drug sellers'prescribing practices in public and private facilities. The use of branded drugs was more common than that of generic drugs in private pharmacies, drug stores and ordinary shops. It is hereby proposed that any intervention should focus on training both facilities in the district on selectively prescribing and rational use of antibiotics for ARI and diarrhoea, and also to prescribe and dispense generic drugs so that it costs patients less when they buy drugs in shops. There is a need to increase awareness in recommending the use of ORS for clients to manage watery and bloody diarrhoea, and ARI in children under five years of age.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17988473     DOI: 10.1258/004947507782333099

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  12 in total

Review 1.  Methods in pharmacoepidemiology: a review of statistical analyses and data reporting in pediatric drug utilization studies.

Authors:  Marco Sequi; Rita Campi; Antonio Clavenna; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2012-07-26       Impact factor: 2.953

Review 2.  Drug prescriptions to outpatient children: a review of the literature.

Authors:  Antonio Clavenna; Maurizio Bonati
Journal:  Eur J Clin Pharmacol       Date:  2009-06-16       Impact factor: 2.953

3.  Evaluation of a social marketing intervention promoting oral rehydration salts in Burundi.

Authors:  Sethson Kassegne; Megan B Kays; Jerome Nzohabonayo
Journal:  BMC Public Health       Date:  2011-03-08       Impact factor: 3.295

4.  Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT).

Authors:  Frank M Ringsted; Isolide S Massawe; Martha M Lemnge; Ib C Bygbjerg
Journal:  Malar J       Date:  2011-08-15       Impact factor: 2.979

5.  Patent medicine sellers: how can they help control childhood malaria?

Authors:  Rosamund M Akuse; Edwin E Eseigbe; Abubakar Ahmed; William R Brieger
Journal:  Malar Res Treat       Date:  2010-09-26

6.  Pattern, awareness and perceptions of health hazards associated with self medication among adult residents of kano metropolis, northwestern Nigeria.

Authors:  Umar M Lawan; Isa S Abubakar; Abubakar M Jibo; Ahmed Rufai
Journal:  Indian J Community Med       Date:  2013-07

Review 7.  Treatment of infections in young infants in low- and middle-income countries: a systematic review and meta-analysis of frontline health worker diagnosis and antibiotic access.

Authors:  Anne C C Lee; Aruna Chandran; Hadley K Herbert; Naoko Kozuki; Perry Markell; Rashed Shah; Harry Campbell; Igor Rudan; Abdullah H Baqui
Journal:  PLoS Med       Date:  2014-10-14       Impact factor: 11.069

8.  Malaria treatment perceptions, practices and influences on provider behaviour: comparing hospitals and non-hospitals in south-east Nigeria.

Authors:  Obinna Onwujekwe; Benjamin Uzochukwu; Nkem Dike; Nkoli Uguru; Emmanuel Nwobi; Elvis Shu
Journal:  Malar J       Date:  2009-10-28       Impact factor: 2.979

Review 9.  Examining characteristics, knowledge and regulatory practices of specialized drug shops in Sub-Saharan Africa: a systematic review of the literature.

Authors:  Francis N Wafula; Eric M Miriti; Catherine A Goodman
Journal:  BMC Health Serv Res       Date:  2012-07-27       Impact factor: 2.655

10.  Improving pharmacy staff knowledge and practice on childhood diarrhea management in Vietnam: are educational interventions effective?

Authors:  Duc Minh Pham; Mona Byrkit; Hoang Van Pham; Trung Pham; Chien Thang Nguyen
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.